Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
- Award ceiling
- Not stated
- Closes
- Sep 7, 2026
- Last verified
- 2026-10-09
Per-recipient award not stated for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, others (see text field entitled "additional information on eligibility" for clarification), private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments, closing Sep 7, 2026.
City or township governmentsCounty governmentsFor profit organizations other than small businessesIndependent school districtsNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Private institutions of higher educationPublic and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesSmall businessesSpecial district governmentsState governmentsEducationHealth & Human Services
In one sentence
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) does not state a per-recipient award amount, open to city or township governments, county governments, for profit organizations other than small businesses, independent…
Record fields
- Program pool (total)
- Not confirmedTotal across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Sep 7, 2026
- Deadline type
- Fixed date
- Opens
- Nov 6, 2024
- Status
- Closed
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- assay development for specific biological targets and disease mechanisms · screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches · hit validation, including implementation of secondary assays · hit-to-lead optimization
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Program pool (total)Across all awards this cycle
Not statedAward ceiling (per project)The most one applicant can receive
Not statedWho can apply?
level
Derived from the source that published this record
entity
City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education
Source field: entity types+5more
, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsindustry
Source field: industries
use
assay development for specific biological targets and disease mechanisms, hit validation, including implementation of secondary assays, hit-to-lead optimization, screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches
Source field: use of fundssize limit
Not confirmed
Source field: applicant size limitclause text
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government;…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
Sep 7, 2026ClosedDeadline type Fixed date
What can the money be used for?
4 categorysThe source’s own spending categories, and what is not parsed.
assay development for specific biological targets and disease mechanismsscreen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approacheshit validation, including implementation of secondary assayshit-to-lead optimization
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Who has received this funding?
4036 awardsAwards on file for this programme, counted rather than modelled.
4036 prior awards on file for this programme, largest first. Every row comes from the funder's own award listing; nothing here is estimated.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | Not stated | $1,996,725 | 2019 |
| APREA THERAPEUTICS, INC. | Not stated | $1,996,571 | 2023 |
| VIEWPOINT MOLECULAR TARGETING, INC. | Not stated | $1,996,306 | 2020 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $1,996,298 | 2023 |
| THOMAS JEFFERSON UNIVERSITY | Not stated | $1,995,283 | 2018 |
| HEALTH RESEARCH, INC. | Not stated | $1,995,235 | 2015 |
| MARKER THERAPEUTICS INC | Not stated | $1,995,000 | 2024 |
| BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | Not stated | $1,994,700 | 2019 |
| MARKER THERAPEUTICS INC | Not stated | $1,994,514 | 2023 |
| SAPIENCE THERAPEUTICS, INC. | Not stated | $1,994,379 | 2021 |
| ETIRARX, INC. | Not stated | $1,994,105 | 2021 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $1,992,452 | 2024 |
| WINSANTOR, INC | Not stated | $1,991,824 | 2021 |
| BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | Not stated | $1,991,787 | 2018 |
| WITS HEALTH CONSORTIUM (PTY) LTD | Not stated | $1,991,270 | 2020 |
| SHASQI INC | Not stated | $1,991,235 | 2021 |
| VYRIAD INC | Not stated | $1,990,950 | 2017 |
| VIRGINIA COMMONWEALTH UNIVERSITY | Not stated | $1,990,427 | 2017 |
| ISOPRENE PHARMACEUTICALS, INC. | Not stated | $1,990,200 | 2021 |
| PHARMAIN CORPORATION | Not stated | $1,990,199 | 2023 |
| PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | Not stated | $1,989,892 | 2015 |
| MEDICAL GUIDANCE SYSTEMS LLC | Not stated | $1,989,846 | 2016 |
| PROTONVDA LLC | Not stated | $1,989,510 | 2020 |
| THE METHODIST HOSPITAL RESEARCH INSTITUTE | Not stated | $1,989,453 | 2022 |
| THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | Not stated | $1,988,539 | 2022 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $1,988,249 | 2018 |
| A&G PHARMACEUTICAL, INC. | Not stated | $1,988,100 | 2012 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,988,000 | 2021 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,988,000 | 2021 |
| EMMYON, INC. | Not stated | $1,987,656 | 2023 |
| THE MEDICAL COLLEGE OF WISCONSIN, INC. | Not stated | $1,987,253 | 2024 |
| STINGINN, LLC | Not stated | $1,987,099 | 2020 |
| FRED HUTCHINSON CANCER CENTER | Not stated | $1,987,091 | 2020 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,986,141 | 2017 |
| THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | Not stated | $1,985,705 | 2023 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,985,578 | 2016 |
| NEW YORK UNIVERSITY | Not stated | $1,985,434 | 2024 |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | Not stated | $1,984,819 | 2022 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $1,984,775 | 2019 |
| SURGICAL INNOVATION ASSOCIATES, INC. | Not stated | $1,984,603 | 2019 |
| NEW YORK UNIVERSITY | Not stated | $1,983,809 | 2024 |
| UNIVERSITY OF ROCHESTER | Not stated | $1,983,747 | 2019 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | Not stated | $1,983,612 | 2021 |
| UNIVERSITY OF WASHINGTON | Not stated | $1,983,331 | 2020 |
| DEEP CREEK PHARMA LLC | Not stated | $1,983,010 | 2023 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | Not stated | $1,982,712 | 2023 |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | Not stated | $1,982,542 | 2020 |
| VIEWPOINT MOLECULAR TARGETING, INC. | Not stated | $1,982,028 | 2017 |
| REGENTS OF THE UNIVERSITY OF MINNESOTA | Not stated | $1,981,598 | 2023 |
| BAYLOR COLLEGE OF MEDICINE | Not stated | $1,981,534 | 2024 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $1,980,732 | 2021 |
| VIRGINIA COMMONWEALTH UNIVERSITY | Not stated | $1,980,208 | 2019 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | Not stated | $1,979,756 | 2024 |
| UNIVERSITY OF FLORIDA | Not stated | $1,979,677 | 2024 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Not stated | $1,979,558 | 2023 |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | Not stated | $1,979,056 | 2020 |
| ABALONE BIO, INC. | Not stated | $1,979,001 | 2019 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | Not stated | $1,978,276 | 2023 |
| UNIVERSITY OF CALIFORNIA, LOS ANGELES | Not stated | $1,978,004 | 2023 |
| PURDUE UNIVERSITY | Not stated | $1,977,792 | 2014 |
| SENEX BIOTECHNOLOGY INC | Not stated | $1,977,275 | 2015 |
| THE JOHNS HOPKINS UNIVERSITY | Not stated | $1,977,270 | 2024 |
| DANA-FARBER CANCER INSTITUTE, INC. | Not stated | $1,976,994 | 2022 |
| FRED HUTCHINSON CANCER CENTER | Not stated | $1,976,767 | 2021 |
| FRED HUTCHINSON CANCER CENTER | Not stated | $1,976,767 | 2021 |
| STEMSYNERGY THERAPEUTICS INC | Not stated | $1,976,591 | 2021 |
| CARTESIAN THERAPEUTICS INC | Not stated | $1,976,452 | 2018 |
| HMH HOSPITALS CORPORATION | Not stated | $1,974,902 | 2017 |
| UNIVERSITY OF ROCHESTER | Not stated | $1,974,083 | 2017 |
| THE GENERAL HOSPITAL CORPORATION | Not stated | $1,973,657 | 2016 |
| CUMBERLAND PHARMACEUTICALS, INC. | Not stated | $1,973,603 | 2018 |
| NORTHWESTERN UNIVERSITY | Not stated | $1,973,417 | 2024 |
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | Not stated | $1,973,120 | 2015 |
| AVANTGEN INC | Not stated | $1,972,824 | 2024 |
| THE UNIVERSITY OF CHICAGO | Not stated | $1,971,022 | 2024 |
| THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | Not stated | $1,970,730 | 2021 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $1,969,653 | 2023 |
| REGENTS OF THE UNIVERSITY OF MINNESOTA | Not stated | $1,969,546 | 2019 |
| THE MEDICAL UNIVERSITY OF SOUTH CAROLINA | Not stated | $1,969,523 | 2019 |
| SIGNALRX PHARMACEUTICALS, INC. | Not stated | $1,968,269 | 2015 |
| SIMPHOTEK, INC. | Not stated | $1,968,105 | 2017 |
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | Not stated | $1,965,536 | 2021 |
| HEALTH RESEARCH, INC. | Not stated | $1,964,953 | 2023 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | Not stated | $1,964,817 | 2019 |
| DANA-FARBER CANCER INSTITUTE, INC. | Not stated | $1,963,974 | 2016 |
| WAYNE STATE UNIVERSITY | Not stated | $1,962,320 | 2019 |
| CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. | Not stated | $1,961,187 | 2022 |
| ENDEAVOR HEALTH CLINICAL OPERATIONS | Not stated | $1,961,125 | 2021 |
| UNIVERSITY OF CALIFORNIA, LOS ANGELES | Not stated | $1,960,702 | 2024 |
| CINCINNATI UNIV OF | Not stated | $1,959,151 | 2021 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | Not stated | $1,957,872 | 2018 |
| VANDERBILT UNIVERSITY MEDICAL CENTER | Not stated | $1,955,664 | 2023 |
| UNIVERSITY OF CALIFORNIA, LOS ANGELES | Not stated | $1,954,977 | 2024 |
| VIEWPOINT MOLECULAR TARGETING, INC. | Not stated | $1,951,675 | 2022 |
| DUKE UNIVERSITY | Not stated | $1,951,674 | 2019 |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | Not stated | $1,950,263 | 2023 |
| H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | Not stated | $1,949,617 | 2024 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $1,949,398 | 2017 |
| MINNETRONIX, INC | Not stated | $1,949,379 | 2016 |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | Not stated | $1,948,691 | 2024 |
Recipient names as published by the California Grants Portal.
What comparable notices state
55 recordsStated ceilings on open records in the same industry.
Among open records stored under Education, 55 of 160 state an award ceiling. Those that do run:
- 25th percentile$172,750
- Median$375,000
- 75th percentile$600,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
4036 awardsAwards under the same assistance listing, not under this notice.
4036 federal awards on file under assistance listing 93.395, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $353,109,533PUBLIC HEALTH INSTITUTECA · FY2014
- $138,088,678OREGON HEALTH & SCIENCE UNIVERSITYOR · FY2014
- $135,357,649THE UNIVERSITY OF CHICAGOIL · FY2014
- $125,672,442NRG ONCOLOGY FOUNDATION INCPA · FY2014
- $115,346,605UNIVERSITY OF SOUTHERN CALIFORNIACA · FY2014
Common questions
5 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- When is the application deadline?
- Sep 7, 2026.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- assay development for specific biological targets and disease mechanisms, screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches, hit validation, including implementation of secondary assays, hit-to-lead optimization, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
- Has this programme funded anyone before?
- 4036 prior awards are on file for this programme, made by National Institutes of Health. Recipients, amounts and fiscal years are listed on this page.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
Also open from National Institutes of Health
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)Closes May 25, 2028Awards Not stated
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)Closes Jun 12, 2028Awards Not stated
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)Closes Jul 16, 2028Awards up to $125,000
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)Closes Oct 9, 2028Awards Not stated
- Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)Closes Not statedAwards Not stated
- Novel Approaches to Advance Precision Aging and Cognitive HealthCloses Not statedAwards Not stated
Also open under assistance listing 93.395
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)Closes Jan 7, 2027Awards up to $500,000
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Closes Jan 7, 2027Awards up to $375,000
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)Closes Sep 25, 2029Awards Not stated
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)Closes Jan 7, 2028Awards Not stated
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)Closes Jan 7, 2028Awards Not stated
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)Closes Oct 19, 2027Awards $50,000 – $300,000
Provenance
Source pagegrants.gov
Retrieved2026-10-09
MethodAutomated check
First seen2026-09-04
Assistance listing93.395
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.